NCT00546728View on ClinicalTrials.gov

The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

Exenatide

exenatide 10 mcg twice daily

DRUG

Metformin

metformin 500 twice daily

Trial Locations (2)

55102

St. Paul Heart Clinic, Saint Paul

55416

International Diabetes Center at Park Nicollet, Saint Louis Park

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

International Diabetes Center at Park Nicollet

OTHER

lead

St. Paul Heart Clinic

OTHER

NCT00546728 - The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes | Biotech Hunter | Biotech Hunter